カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の転移性がん治療薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Metastatic Cancer Treat Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO20810）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO20810
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：100
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の転移性がん治療薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

転移性がん治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の転移性がん治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

転移性がん治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・化学療法剤、標的治療剤

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界の転移性がん治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Roche、Merck、Johnson and Johnson、Eli Lilly、Sun Pharmaceutical、Bayer、Gilead Sciences、GlaxoSmithKline、Novartis、Pfizer、AstraZeneca

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、転移性がん治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な転移性がん治療薬メーカーの企業概要、2019年～2022年までの転移性がん治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な転移性がん治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別転移性がん治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの転移性がん治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での転移性がん治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および転移性がん治療薬の産業チェーンを掲載しています。
・第13、14、15章では、転移性がん治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 転移性がん治療薬の概要
- 種類別分析（2017年vs2021年vs2028年）：化学療法剤、標的治療剤
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界の転移性がん治療薬市場規模・予測
- 世界の転移性がん治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Roche、Merck、Johnson and Johnson、Eli Lilly、Sun Pharmaceutical、Bayer、Gilead Sciences、GlaxoSmithKline、Novartis、Pfizer、AstraZeneca
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：化学療法剤、標的治療剤
・用途別分析2017年-2028年：病院、診療所、その他
・転移性がん治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・転移性がん治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・転移性がん治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・転移性がん治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・転移性がん治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Metastatic Cancer Treat Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Metastatic Cancer Treat Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Metastatic Cancer Treat Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Chemotherapy Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Metastatic Cancer Treat Drug include Roche, Merck, Johnson and Johnson, Eli Lilly, and Sun Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Metastatic Cancer Treat Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapy Drugs
Targeted Therapy Drugs
Market segment by Application can be divided into
Hospitals
Clinics
Other
The key market players for global Metastatic Cancer Treat Drug market are listed below:
Roche
Merck
Johnson and Johnson
Eli Lilly
Sun Pharmaceutical
Bayer
Gilead Sciences
GlaxoSmithKline
Novartis
Pfizer
AstraZeneca
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Metastatic Cancer Treat Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Metastatic Cancer Treat Drug, with price, sales, revenue and global market share of Metastatic Cancer Treat Drug from 2019 to 2022.
Chapter 3, the Metastatic Cancer Treat Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metastatic Cancer Treat Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Metastatic Cancer Treat Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Metastatic Cancer Treat Drug.
Chapter 13, 14, and 15, to describe Metastatic Cancer Treat Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Metastatic Cancer Treat Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Metastatic Cancer Treat Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Chemotherapy Drugs
1.2.3 Targeted Therapy Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Metastatic Cancer Treat Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Metastatic Cancer Treat Drug Market Size & Forecast
1.4.1 Global Metastatic Cancer Treat Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Metastatic Cancer Treat Drug Sales in Volume (2017-2028)
1.4.3 Global Metastatic Cancer Treat Drug Price (2017-2028)
1.5 Global Metastatic Cancer Treat Drug Production Capacity Analysis
1.5.1 Global Metastatic Cancer Treat Drug Total Production Capacity (2017-2028)
1.5.2 Global Metastatic Cancer Treat Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Metastatic Cancer Treat Drug Market Drivers
1.6.2 Metastatic Cancer Treat Drug Market Restraints
1.6.3 Metastatic Cancer Treat Drug Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Metastatic Cancer Treat Drug Product and Services
2.1.4 Roche Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Metastatic Cancer Treat Drug Product and Services
2.2.4 Merck Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Johnson and Johnson
2.3.1 Johnson and Johnson Details
2.3.2 Johnson and Johnson Major Business
2.3.3 Johnson and Johnson Metastatic Cancer Treat Drug Product and Services
2.3.4 Johnson and Johnson Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly Metastatic Cancer Treat Drug Product and Services
2.4.4 Eli Lilly Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sun Pharmaceutical
2.5.1 Sun Pharmaceutical Details
2.5.2 Sun Pharmaceutical Major Business
2.5.3 Sun Pharmaceutical Metastatic Cancer Treat Drug Product and Services
2.5.4 Sun Pharmaceutical Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business
2.6.3 Bayer Metastatic Cancer Treat Drug Product and Services
2.6.4 Bayer Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Gilead Sciences
2.7.1 Gilead Sciences Details
2.7.2 Gilead Sciences Major Business
2.7.3 Gilead Sciences Metastatic Cancer Treat Drug Product and Services
2.7.4 Gilead Sciences Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business
2.8.3 GlaxoSmithKline Metastatic Cancer Treat Drug Product and Services
2.8.4 GlaxoSmithKline Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Metastatic Cancer Treat Drug Product and Services
2.9.4 Novartis Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Metastatic Cancer Treat Drug Product and Services
2.10.4 Pfizer Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Metastatic Cancer Treat Drug Product and Services
2.11.4 AstraZeneca Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Metastatic Cancer Treat Drug Breakdown Data by Manufacturer
3.1 Global Metastatic Cancer Treat Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Metastatic Cancer Treat Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Metastatic Cancer Treat Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Metastatic Cancer Treat Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Metastatic Cancer Treat Drug Manufacturer Market Share in 2021
3.5 Global Metastatic Cancer Treat Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Metastatic Cancer Treat Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Metastatic Cancer Treat Drug Market Size by Region
4.1.1 Global Metastatic Cancer Treat Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Metastatic Cancer Treat Drug Revenue by Region (2017-2028)
4.2 North America Metastatic Cancer Treat Drug Revenue (2017-2028)
4.3 Europe Metastatic Cancer Treat Drug Revenue (2017-2028)
4.4 Asia-Pacific Metastatic Cancer Treat Drug Revenue (2017-2028)
4.5 South America Metastatic Cancer Treat Drug Revenue (2017-2028)
4.6 Middle East and Africa Metastatic Cancer Treat Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Metastatic Cancer Treat Drug Sales in Volume by Type (2017-2028)
5.2 Global Metastatic Cancer Treat Drug Revenue by Type (2017-2028)
5.3 Global Metastatic Cancer Treat Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Metastatic Cancer Treat Drug Sales in Volume by Application (2017-2028)
6.2 Global Metastatic Cancer Treat Drug Revenue by Application (2017-2028)
6.3 Global Metastatic Cancer Treat Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Metastatic Cancer Treat Drug Sales by Type (2017-2028)
7.2 North America Metastatic Cancer Treat Drug Sales by Application (2017-2028)
7.3 North America Metastatic Cancer Treat Drug Market Size by Country
7.3.1 North America Metastatic Cancer Treat Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Metastatic Cancer Treat Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Metastatic Cancer Treat Drug Sales by Type (2017-2028)
8.2 Europe Metastatic Cancer Treat Drug Sales by Application (2017-2028)
8.3 Europe Metastatic Cancer Treat Drug Market Size by Country
8.3.1 Europe Metastatic Cancer Treat Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Metastatic Cancer Treat Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Metastatic Cancer Treat Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Metastatic Cancer Treat Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Metastatic Cancer Treat Drug Market Size by Region
9.3.1 Asia-Pacific Metastatic Cancer Treat Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Metastatic Cancer Treat Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Metastatic Cancer Treat Drug Sales by Type (2017-2028)
10.2 South America Metastatic Cancer Treat Drug Sales by Application (2017-2028)
10.3 South America Metastatic Cancer Treat Drug Market Size by Country
10.3.1 South America Metastatic Cancer Treat Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Metastatic Cancer Treat Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Metastatic Cancer Treat Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Metastatic Cancer Treat Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Metastatic Cancer Treat Drug Market Size by Country
11.3.1 Middle East & Africa Metastatic Cancer Treat Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Metastatic Cancer Treat Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Metastatic Cancer Treat Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Metastatic Cancer Treat Drug
12.3 Metastatic Cancer Treat Drug Production Process
12.4 Metastatic Cancer Treat Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Metastatic Cancer Treat Drug Typical Distributors
13.3 Metastatic Cancer Treat Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Metastatic Cancer Treat Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Metastatic Cancer Treat Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Metastatic Cancer Treat Drug Product and Services
Table 6. Roche Metastatic Cancer Treat Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Metastatic Cancer Treat Drug Product and Services
Table 10. Merck Metastatic Cancer Treat Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 12. Johnson and Johnson Major Business
Table 13. Johnson and Johnson Metastatic Cancer Treat Drug Product and Services
Table 14. Johnson and Johnson Metastatic Cancer Treat Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 16. Eli Lilly Major Business
Table 17. Eli Lilly Metastatic Cancer Treat Drug Product and Services
Table 18. Eli Lilly Metastatic Cancer Treat Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Sun Pharmaceutical Major Business
Table 21. Sun Pharmaceutical Metastatic Cancer Treat Drug Product and Services
Table 22. Sun Pharmaceutical Metastatic Cancer Treat Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Bayer Basic Information, Manufacturing Base and Competitors
Table 24. Bayer Major Business
Table 25. Bayer Metastatic Cancer Treat Drug Product and Services
Table 26. Bayer Metastatic Cancer Treat Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 28. Gilead Sciences Major Business
Table 29. Gilead Sciences Metastatic Cancer Treat Drug Product and Services
Table 30. Gilead Sciences Metastatic Cancer Treat Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 32. GlaxoSmithKline Major Business
Table 33. GlaxoSmithKline Metastatic Cancer Treat Drug Product and Services
Table 34. GlaxoSmithKline Metastatic Cancer Treat Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Novartis Basic Information, Manufacturing Base and Competitors
Table 36. Novartis Major Business
Table 37. Novartis Metastatic Cancer Treat Drug Product and Services
Table 38. Novartis Metastatic Cancer Treat Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Pfizer Basic Information, Manufacturing Base and Competitors
Table 40. Pfizer Major Business
Table 41. Pfizer Metastatic Cancer Treat Drug Product and Services
Table 42. Pfizer Metastatic Cancer Treat Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Major Business
Table 45. AstraZeneca Metastatic Cancer Treat Drug Product and Services
Table 46. AstraZeneca Metastatic Cancer Treat Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Metastatic Cancer Treat Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 48. Global Metastatic Cancer Treat Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Metastatic Cancer Treat Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Metastatic Cancer Treat Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Metastatic Cancer Treat Drug Production Site of Key Manufacturer
Table 52. Metastatic Cancer Treat Drug New Entrant and Capacity Expansion Plans
Table 53. Metastatic Cancer Treat Drug Mergers & Acquisitions in the Past Five Years
Table 54. Global Metastatic Cancer Treat Drug Sales by Region (2017-2022) & (K Units)
Table 55. Global Metastatic Cancer Treat Drug Sales by Region (2023-2028) & (K Units)
Table 56. Global Metastatic Cancer Treat Drug Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Metastatic Cancer Treat Drug Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Metastatic Cancer Treat Drug Sales by Type (2017-2022) & (K Units)
Table 59. Global Metastatic Cancer Treat Drug Sales by Type (2023-2028) & (K Units)
Table 60. Global Metastatic Cancer Treat Drug Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Metastatic Cancer Treat Drug Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Metastatic Cancer Treat Drug Price by Type (2017-2022) & (US$/Unit)
Table 63. Global Metastatic Cancer Treat Drug Price by Type (2023-2028) & (US$/Unit)
Table 64. Global Metastatic Cancer Treat Drug Sales by Application (2017-2022) & (K Units)
Table 65. Global Metastatic Cancer Treat Drug Sales by Application (2023-2028) & (K Units)
Table 66. Global Metastatic Cancer Treat Drug Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Metastatic Cancer Treat Drug Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Metastatic Cancer Treat Drug Price by Application (2017-2022) & (US$/Unit)
Table 69. Global Metastatic Cancer Treat Drug Price by Application (2023-2028) & (US$/Unit)
Table 70. North America Metastatic Cancer Treat Drug Sales by Country (2017-2022) & (K Units)
Table 71. North America Metastatic Cancer Treat Drug Sales by Country (2023-2028) & (K Units)
Table 72. North America Metastatic Cancer Treat Drug Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Metastatic Cancer Treat Drug Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Metastatic Cancer Treat Drug Sales by Type (2017-2022) & (K Units)
Table 75. North America Metastatic Cancer Treat Drug Sales by Type (2023-2028) & (K Units)
Table 76. North America Metastatic Cancer Treat Drug Sales by Application (2017-2022) & (K Units)
Table 77. North America Metastatic Cancer Treat Drug Sales by Application (2023-2028) & (K Units)
Table 78. Europe Metastatic Cancer Treat Drug Sales by Country (2017-2022) & (K Units)
Table 79. Europe Metastatic Cancer Treat Drug Sales by Country (2023-2028) & (K Units)
Table 80. Europe Metastatic Cancer Treat Drug Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Metastatic Cancer Treat Drug Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Metastatic Cancer Treat Drug Sales by Type (2017-2022) & (K Units)
Table 83. Europe Metastatic Cancer Treat Drug Sales by Type (2023-2028) & (K Units)
Table 84. Europe Metastatic Cancer Treat Drug Sales by Application (2017-2022) & (K Units)
Table 85. Europe Metastatic Cancer Treat Drug Sales by Application (2023-2028) & (K Units)
Table 86. Asia-Pacific Metastatic Cancer Treat Drug Sales by Region (2017-2022) & (K Units)
Table 87. Asia-Pacific Metastatic Cancer Treat Drug Sales by Region (2023-2028) & (K Units)
Table 88. Asia-Pacific Metastatic Cancer Treat Drug Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Metastatic Cancer Treat Drug Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Metastatic Cancer Treat Drug Sales by Type (2017-2022) & (K Units)
Table 91. Asia-Pacific Metastatic Cancer Treat Drug Sales by Type (2023-2028) & (K Units)
Table 92. Asia-Pacific Metastatic Cancer Treat Drug Sales by Application (2017-2022) & (K Units)
Table 93. Asia-Pacific Metastatic Cancer Treat Drug Sales by Application (2023-2028) & (K Units)
Table 94. South America Metastatic Cancer Treat Drug Sales by Country (2017-2022) & (K Units)
Table 95. South America Metastatic Cancer Treat Drug Sales by Country (2023-2028) & (K Units)
Table 96. South America Metastatic Cancer Treat Drug Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Metastatic Cancer Treat Drug Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Metastatic Cancer Treat Drug Sales by Type (2017-2022) & (K Units)
Table 99. South America Metastatic Cancer Treat Drug Sales by Type (2023-2028) & (K Units)
Table 100. South America Metastatic Cancer Treat Drug Sales by Application (2017-2022) & (K Units)
Table 101. South America Metastatic Cancer Treat Drug Sales by Application (2023-2028) & (K Units)
Table 102. Middle East & Africa Metastatic Cancer Treat Drug Sales by Region (2017-2022) & (K Units)
Table 103. Middle East & Africa Metastatic Cancer Treat Drug Sales by Region (2023-2028) & (K Units)
Table 104. Middle East & Africa Metastatic Cancer Treat Drug Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Metastatic Cancer Treat Drug Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Metastatic Cancer Treat Drug Sales by Type (2017-2022) & (K Units)
Table 107. Middle East & Africa Metastatic Cancer Treat Drug Sales by Type (2023-2028) & (K Units)
Table 108. Middle East & Africa Metastatic Cancer Treat Drug Sales by Application (2017-2022) & (K Units)
Table 109. Middle East & Africa Metastatic Cancer Treat Drug Sales by Application (2023-2028) & (K Units)
Table 110. Metastatic Cancer Treat Drug Raw Material
Table 111. Key Manufacturers of Metastatic Cancer Treat Drug Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Metastatic Cancer Treat Drug Typical Distributors
Table 115. Metastatic Cancer Treat Drug Typical Customers
List of Figures
Figure 1. Metastatic Cancer Treat Drug Picture
Figure 2. Global Metastatic Cancer Treat Drug Revenue Market Share by Type in 2021
Figure 3. Chemotherapy Drugs
Figure 4. Targeted Therapy Drugs
Figure 5. Global Metastatic Cancer Treat Drug Revenue Market Share by Application in 2021
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Other
Figure 9. Global Metastatic Cancer Treat Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Metastatic Cancer Treat Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Metastatic Cancer Treat Drug Sales (2017-2028) & (K Units)
Figure 12. Global Metastatic Cancer Treat Drug Price (2017-2028) & (US$/Unit)
Figure 13. Global Metastatic Cancer Treat Drug Production Capacity (2017-2028) & (K Units)
Figure 14. Global Metastatic Cancer Treat Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Metastatic Cancer Treat Drug Market Drivers
Figure 16. Metastatic Cancer Treat Drug Market Restraints
Figure 17. Metastatic Cancer Treat Drug Market Trends
Figure 18. Global Metastatic Cancer Treat Drug Sales Market Share by Manufacturer in 2021
Figure 19. Global Metastatic Cancer Treat Drug Revenue Market Share by Manufacturer in 2021
Figure 20. Metastatic Cancer Treat Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Metastatic Cancer Treat Drug Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Metastatic Cancer Treat Drug Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Metastatic Cancer Treat Drug Sales Market Share by Region (2017-2028)
Figure 24. Global Metastatic Cancer Treat Drug Revenue Market Share by Region (2017-2028)
Figure 25. North America Metastatic Cancer Treat Drug Revenue (2017-2028) & (USD Million)
Figure 26. Europe Metastatic Cancer Treat Drug Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Metastatic Cancer Treat Drug Revenue (2017-2028) & (USD Million)
Figure 28. South America Metastatic Cancer Treat Drug Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Metastatic Cancer Treat Drug Revenue (2017-2028) & (USD Million)
Figure 30. Global Metastatic Cancer Treat Drug Sales Market Share by Type (2017-2028)
Figure 31. Global Metastatic Cancer Treat Drug Revenue Market Share by Type (2017-2028)
Figure 32. Global Metastatic Cancer Treat Drug Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Metastatic Cancer Treat Drug Sales Market Share by Application (2017-2028)
Figure 34. Global Metastatic Cancer Treat Drug Revenue Market Share by Application (2017-2028)
Figure 35. Global Metastatic Cancer Treat Drug Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Metastatic Cancer Treat Drug Sales Market Share by Type (2017-2028)
Figure 37. North America Metastatic Cancer Treat Drug Sales Market Share by Application (2017-2028)
Figure 38. North America Metastatic Cancer Treat Drug Sales Market Share by Country (2017-2028)
Figure 39. North America Metastatic Cancer Treat Drug Revenue Market Share by Country (2017-2028)
Figure 40. United States Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Metastatic Cancer Treat Drug Sales Market Share by Type (2017-2028)
Figure 44. Europe Metastatic Cancer Treat Drug Sales Market Share by Application (2017-2028)
Figure 45. Europe Metastatic Cancer Treat Drug Sales Market Share by Country (2017-2028)
Figure 46. Europe Metastatic Cancer Treat Drug Revenue Market Share by Country (2017-2028)
Figure 47. Germany Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Metastatic Cancer Treat Drug Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Metastatic Cancer Treat Drug Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Metastatic Cancer Treat Drug Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Metastatic Cancer Treat Drug Revenue Market Share by Region (2017-2028)
Figure 56. China Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Metastatic Cancer Treat Drug Sales Market Share by Type (2017-2028)
Figure 63. South America Metastatic Cancer Treat Drug Sales Market Share by Application (2017-2028)
Figure 64. South America Metastatic Cancer Treat Drug Sales Market Share by Country (2017-2028)
Figure 65. South America Metastatic Cancer Treat Drug Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Metastatic Cancer Treat Drug Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Metastatic Cancer Treat Drug Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Metastatic Cancer Treat Drug Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Metastatic Cancer Treat Drug Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Metastatic Cancer Treat Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Metastatic Cancer Treat Drug in 2021
Figure 77. Manufacturing Process Analysis of Metastatic Cancer Treat Drug
Figure 78. Metastatic Cancer Treat Drug Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 抗がん剤曝露評価サービスのグローバル市場展望 2023年-2029年：がん標的治療薬、免疫療法薬、その他
  • 膵臓＆胆管がん治療薬の世界市場 2022年-2026年
  • がん薬物治療のグローバル市場展望 2023年-2029年：標的治療、化学治療、免疫治療
  • プロピオン酸血症治療薬のグローバル市場展望 2023年-2029年：ブドウ糖点滴療法、抗生物質、重炭酸点滴静注、ビオチンサプリメント、その他
  • 世界のゴセレリン薬物市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO20810 )"世界の転移性がん治療薬市場2022年：市場規模予測（～2028年）" (英文：Global Metastatic Cancer Treat Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。